Invention Grant
- Patent Title: Truncated L1 protein of human papillomavirus type 58
- Patent Title (中): 人乳头状瘤病毒的切断的L1蛋白58型
-
Application No.: US13810581Application Date: 2011-07-15
-
Publication No.: US09382296B2Publication Date: 2016-07-05
- Inventor: Shaowei Li , Minxi Wei , Xianglin Kong , Yingbin Wang , Jun Zhang , Ningshao Xia
- Applicant: Shaowei Li , Minxi Wei , Xianglin Kong , Yingbin Wang , Jun Zhang , Ningshao Xia
- Applicant Address: CN Fujian Province CN Fujian
- Assignee: XIAMEN UNIVERSITY,XIAMEN INNOVAX BIOTECH CO., LTD.
- Current Assignee: XIAMEN UNIVERSITY,XIAMEN INNOVAX BIOTECH CO., LTD.
- Current Assignee Address: CN Fujian Province CN Fujian
- Agency: Banner & Witcoff, Ltd.
- Priority: CN201010232875 20100716
- International Application: PCT/CN2011/077184 WO 20110715
- International Announcement: WO2012/006962 WO 20120119
- Main IPC: C07K14/025
- IPC: C07K14/025 ; A61K39/12 ; C07K14/005 ; A61K39/00 ; A61K38/00
Abstract:
Provided are an N-terminal truncated L1 protein of the Human Papillomavirus Type 58, a coding sequence and preparation method thereof, and a virus-like particle comprising the protein. Uses of the protein and the virus-like particle in the preparation of a pharmaceutical composition or a vaccine are further provided. The pharmaceutical composition or vaccine is used for prevention of HPV infection and a disease caused by HPV infection.
Public/Granted literature
- US20130315943A1 TRUNCATED L1 PROTEIN OF HUMAN PAPILLOMAVIRUS TYPE 58 Public/Granted day:2013-11-28
Information query
